coplug
    Back to PCN explorer
    PCN reports · Core20PLUS5

    Heatons Group Network PCN, Stockport (LAD) · Health Inequalities Profile

    PCN U15435 · NHS Greater Manchester Integrated Care Board · 3 GP practices

    Read the report

    This report is generated by Coplug's Healthcare Agent. Log in to ask further questions of it, add the spatial context, or create new enquiries to better understand and improve your Neighbourhood's Health

    01 / 15

    Board summary

    Key figures

    72,952

    Registered population

    62.3% aged 18–64

    17.0%

    Aged 65+

    ICB 14.9% · England 17.9%

    19.0%

    In IMD quintile 1

    ICB 40.7% · England 21.0%

    ~13,996

    Core20 residents (est.)

    Resident basis; registered basis ~14,216 · see page 3

    10,446

    Hypertension register

    +5.97% in 3 yrs · England +5.60%

    846

    SMI register

    25.3% of Stockport (LAD)'s

    1,442

    COPD register

    Reviews +0.65% in 3 yrs

    Forecast to 2030

    12,286

    Hypertension patients, 2030

    +1,840 on today

    69.2%

    QRISK ≥20% on statins, 2030

    +1.88pp over 3 yrs

    5.0%

    Cancer prevalence, 2030

    England 4.5%

    Three things the board should see

    68.0%
    Hypertension control lags despite high BP recording.

    Treatment to target fell 3.7 pp (England +2.5 pp) to 68.0% (Stockport 73.6%), despite 88.1% recent BP recording, which may reflect unverified titration gaps.

    59.6%
    Annual asthma reviews fell behind benchmarks.

    Asthma review coverage fell 3.1 pp (England +2.8 pp) to 59.6% (England 65.7%), leaving about 2,100 patients unreviewed across the PCN.

    60.2%
    Diabetes HbA1c and statin delivery exceed England.

    Diabetes HbA1c control without frailty reaches 60.2% (England 57.4%), while primary prevention statin prescribing in diabetes stands at 77.2% (England 73.2%).

    Sources & context

    PCN and practice-level primary care data; ICB and provider context on page 8

    Powered by Coplug · Page 1 of 15
    02 / 15

    Population, age and ethnicity

    A younger population than Stockport sits alongside 31 catchment care homes

    Across 72,952 registered patients, the PCN has a younger age profile than the borough. Patients aged 65+ comprise 17.0% (12,403 patients), below Stockport (19.7%) and England (17.9%), but above NHS Greater Manchester ICB (14.9%). Children aged 0-17 represent 20.7% (15,077 patients), above Stockport (19.7%) and England (19.6%), but below the ICB (21.8%). Census data record 0.0% Gypsy or Irish Traveller and 0.1% Roma residents. Practice lists range from 8,495 at Heaton Mersey Med.pract. to 54,561 at Heaton Moor Medical Group. Projected list growth to 2030 is 2.2%, though projection methodology is unverified.

    Age profile

    0–1720.7%
    18–6462.3%
    65+17.0%

    65+: ICB 14.9%, England 17.9%

    Older people · falls rows are Stockport (LAD) local-authority (LA) data, not PCN

    MeasureLocalNorth WestEnglandPeriod
    Falls admissions, 65+, per 100,000 (Stockport LA)2,0722,0711,9582024/25
    Diabetes with frailty: HbA1c ≤75 mmol/mol (PCN)87.6%82.9%81.9%2024/25
    Diabetes without frailty: HbA1c ≤58 mmol/mol (PCN)60.3%56.6%57.4%2024/25
    Falls admissions, 65 to 79, per 100,000 (Stockport LA)9191,0219552024/25
    Falls deaths, all ages, per 100,000 (Stockport LA)23.718.214.82022‑24
    Sources & context

    Census 2021; Fingertips falls and diabetes. Falls are local-authority data. Ethnic minority = 100% minus White

    Powered by Coplug · Page 2 of 15
    03 / 15

    Deprivation and Core20

    Core20 share is 19.0% overall but practice shares vary by 40.0 percentage points

    Across the PCN, 19.0% of registered patients live in Core20 areas, above Stockport (16.1%) but below England (21.0%). Deprivation is unevenly distributed: Manor Medical Practice has the highest concentration at 40.01% (3,959 estimated patients), Heaton Moor Medical Group holds the largest volume at 10,257 estimated patients (18.8%), and Heaton Mersey Med.pract. records 0.0%. Practice shares diverge by 40.0 pp, and weighted practice share (19.5%) slightly exceeds the PCN rate. Differentiated outreach must balance high practice concentration against large absolute patient volume.

    % of patients in IMD quintile 1, by practice

    Dashed line: England 21.0% · right column: Core20 patients, registered basis

    Manor Medical40.0% · 3,959 patients
    Heaton Moor18.8% · 10,257 patients
    Heaton Mersey0.0% · 0 patients
    Sources & context

    Deprivation: Index of Multiple Deprivation, applied to registered patients

    Powered by Coplug · Page 3 of 15
    04 / 15

    PLUS groups and inclusion health

    PLUS groups and inclusion health

    846

    SMI register

    1.17% recorded prevalence

    414

    Learning disability register

    0.57% recorded prevalence

    31

    Care homes, 1,085 beds

    In the PCN catchment

    9.5%

    Provide unpaid care

    Stockport (LAD), Census 2021

    Severe mental illness prevalence is 1.2% (846 patients), exceeding Stockport (1.0%), the ICB (1.1%), and England (1.0%). The learning disability register records 414 patients (0.6%, matching all benchmarks). The PCN catchment contains 31 care homes with 1,085 beds, though bed capacity does not establish occupancy or registered resident counts. Higher severe mental illness prevalence than borough and national rates indicates demand for routine physical health monitoring.

    Severe mental illness: physical health checks

    Across 846 severe mental illness patients (1.2% prevalence), blood pressure recording is 79.3% (Stockport 85.0%; England 83.4%) and BMI recording is 79.7% (Stockport 84.0%; England 82.1%).

    Sources & context

    QOF registers; Census 2021 carers; care homes and homelessness as supplied. Carers and homelessness are local-authority data

    Powered by Coplug · Page 4 of 15
    05 / 15

    Clinical focus: hypertension and lipids

    Clinical focus: hypertension and lipids

    10,446

    Hypertension register

    +5.97%

    Register growth, 3 yrs

    Stockport (LAD) +4.99% · England +5.60%

    −2.84pp

    BP control, under 80

    ≤140/90 · −1.24pp aged 80+

    +1,840

    More patients by 2030

    Forecast 12,286 (16.21%)

    Hypertension case-finding and control

    Hypertension prevalence is 14.4% (10,446 patients), below Stockport (16.2%) and England (15.2%), though recent blood pressure recording is 88.1% (Stockport 91.2%; England 90.0%). However, blood pressure control to threshold fell 3.7 pp over 2023 to 2025 (England +2.5 pp) to 68.0% (Stockport 73.6%; England 70.3%). Among patients aged under 80, control is 66.4% (Stockport 70.8%; England 67.8%), dropping to 65.3% at Heaton Moor Medical Group. Crude prevalence gaps may reflect the PCN's younger age profile rather than missed detection. Slipping control despite high recording suggests that post-screening medication titration and clinical review require PCN-wide prioritisation.

    Lipids and statins

    Statin treatment for diabetes without CVD reached 77.2% (England 73.2%; Stockport 74.2%), and QRISK 20% and over coverage is 65.3% (England 63.6%; Stockport 64.8%). Strong lipid-lowering therapy in high-risk cohorts places the PCN above national benchmarks, so sustaining routine annual review should remain the clinical priority.

    MeasureItemsCost / itemICBEnglandAnnual spend
    Lipid-modifying, 2026147,769£1.70£1.94£1.86£251,207
    Cardiovascular (all), 2025201,215£2.84£3.15£3.33£571,451

    For lipid-modifying drugs in 2026, the PCN prescribed 147,769 items at £1.70 per item (Stockport £1.99; NHS Greater Manchester ICB £1.94; England £1.86), spending £23,643 less than at England's unit cost. Spending less per item than England allows review capacity to focus on clinical appropriateness rather than formulary cost-cutting.

    Sources & context

    QOF hypertension register and BP control indicators; prescribing items and cost as supplied

    Powered by Coplug · Page 5 of 15
    06 / 15

    Clinical focus: respiratory, cancer register and children

    Clinical focus: respiratory, cancer register and children

    Respiratory

    −5.00%

    Asthma reviews, PCN 3-yr % change

    +4.44%

    Asthma reviews, England 3-yr % change

    −1.60%

    Asthma prevalence, PCN 3-yr % change

    Asthma prevalence is 7.6% (5,142 patients; England 6.6%), and asthma prescribing for ages 5–19 reached 1,760 items per 1,000 (England 1,488). However, annual asthma reviews fell 3.1 pp over 2023 to 2025 (England +2.8 pp) to 59.6% (Stockport 63.4%; England 65.7%), leaving about 2,100 patients unreviewed. Conversely, COPD reviews reached 78.2% (Stockport 76.4%; England 76.4%) even as the COPD register fell 5.7% (England +2.6%). Second-hand smoke status was recorded for 81.5% of asthma patients aged 6–19 (England 78.8%).

    Cancer register and children's immunisation

    The cancer register rose +11.4% over 2023 to 2025 (England +9.0%) to 2,917 patients (4.0% prevalence; England 3.8%). In childhood immunisations, MMR dose 1 reached 98.0% at age 5, but MMR dose 2 was 93.4% (below the 95.0% target by 1.6 pp; 4.6 pp below dose 1). The 4-in-1 pre-school booster was 88.3% (below the 95.0% target by 6.7 pp).

    Dashed line: 95% national coverage target · solid tick: England

    6-in-1 at 12 months95.0%

    England 91.0%

    6-in-1 complete primary course at 24 months96.8%

    England 92.2%

    MMR dose 1 at 24 months96.8%

    England 88.3%

    MMR dose 2 at age 593.4%

    England 82.8%

    4-in-1 pre-school booster at age 588.3%

    England 80.9%

    Sources & context

    QOF registers and review indicators; childhood immunisation coverage as supplied

    Powered by Coplug · Page 6 of 15
    07 / 15

    Early cancer diagnosis

    Early cancer diagnosis

    55.6%

    Greater Manchester ICB, stage 1–2

    55.3%

    England, 2022

    75%

    National ambition by 2028

    ~2,270

    Extra early-stage cases a year to reach the ambition

    Stage 1–2 share by cancer type, 2022Greater Manchester ICBEnglandNo usable stageStaged cancers
    Lung40.4%33.8%15%2,193
    Prostate61.7%53.2%14%1,788
    Breast82.5%85.4%19%1,758
    Bowel46.3%47.0%19%1,427
    Skin cancer84.5%87.8%27%580

    Across NHS Greater Manchester ICB in 2022, 55.6% of staged cancers were diagnosed at stage 1 or 2 (England 55.3%), sitting 19.4 pp below the 75.0% national ambition by 2028. Staging completeness was 70.8% (England 67.0%), leaving about 2,270 additional early-stage diagnoses required annually across the ICB to reach the ambition. ICB staging describes system pathways, not PCN performance. Locally, the PCN cancer register grew +11.4% over 2023 to 2025 (England +9.0%) to 2,917 patients (4.0% prevalence). Breast screening coverage (aged 53 to 70) rose +19.6% over 2023 to 2024 (England +8.4%) to 67.8% (Stockport 72.6%; England 69.9%), with Heaton Moor Medical Group at 65.6%.

    Sources & context

    Stage at diagnosis: National Disease Registration Service

    Powered by Coplug · Page 7 of 15
    08 / 15

    Cancer waits, diagnostics and community services

    Cancer waits, diagnostics and community services

    Cancer waits and diagnostics, Jul 2026 (provisional)

    In July 2026, Stockport NHS Foundation Trust recorded 83.2% on 28-day faster diagnosis (standard 75.0%) and 97.4% on 31-day treatment (standard 96.0%). However, 62-day referral to treatment was 74.7%, below the 85.0% standard by 10.3 pp, against Tameside and Glossop Integrated Care NHS Foundation Trust (76.8%), Manchester University NHS Foundation Trust (72.8%), NHS Greater Manchester Integrated Care Board (75.7%) and England (71.2%). For diagnostic tests, 14.1% waited 6+ weeks at Stockport NHS Foundation Trust (Tameside and Glossop Integrated Care NHS Foundation Trust 0.8%; Manchester University NHS Foundation Trust 9.0%; England 23.1%). Provider data reflects trust performance, not the PCN.

    Pathways within standard (%)StockportManchesterTameside and Glossop Integrated CareGreater Manchester ICBEngland
    28-day faster diagnosis (75%)83.2180.0682.4879.5379.32
    31-day treatment (96%)97.3992.5496.2596.4992.50
    62-day referral to treatment (85%)74.6772.8576.7775.7371.16
    Diagnostic waits over 6 weeks (%)StockportManchesterTameside and Glossop Integrated CareEngland
    MRI1.4111.680.0021.40
    CT2.9314.660.189.92
    Echocardiography17.464.910.0028.48
    Colonoscopy5.534.511.5130.83
    Gastroscopy5.3129.355.4529.02
    All 15 DM01 tests14.088.980.8023.14
    Community services activityStockport residentsGreater Manchester ICB
    Care contacts57,085573,310
    Referrals10,69094,470
    Patients with a contact16,950183,535

    Community services (residents of Stockport), Jun 2026 (provisional). In June 2026, Stockport residents recorded 57,085 community care contacts, 7,980 care activities, and 16,950 individual patients with a contact, with adults aged 65+ accounting for 60.6% of contacts. Across NHS Greater Manchester Integrated Care Board, there were 573,310 contacts and 474,760 activities. Figures reflect provisional experimental data from submitting providers and do not establish unique PCN patient activity.

    Sources & context

    Waits and diagnostics: NHS England monthly statistics · ICB and provider data, not PCN

    Powered by Coplug · Page 8 of 15
    09 / 15

    Practice variation and patient experience

    GPPS phone access spans a 32.5 pp spread between network practices

    Overall 2025/26 QOF achievement ranges from 96.5% at Heaton Mersey Med.pract. to 98.7% at Manor Medical Practice (England 92.5%). However, vaccination and immunisation domain achievement varies across a 17.3 pp spread, from 71.4% at Heaton Moor Medical Group to 88.7% at Manor Medical Practice.

    GP Patient Survey by practice

    PracticeResponses% in IMD Q1Phone easyRequest led to apptOverall good
    Manor Medical12040.088.7%83.9%97.2%
    Heaton Mersey930.084.3%68.4%85.1%
    Heaton Moor13118.856.2%65.1%75.8%
    England—~2156.9%71.6%76.7%
    Sources & context

    QOF achievement; GP Patient Survey, practice-level results

    Powered by Coplug · Page 9 of 15
    11 / 15

    What the data can't tell us: gaps and local assets

    What the data can't tell us: gaps and local assets

    Local assets and voluntary sectorPCNStockport (LAD)AssetPCNStockport (LAD)
    Care homes (catchment)31 (1,085 beds)n/aSchools (catchment)119n/a
    Children's centres22Places of worship68135
    Libraries612Food banks (VCS)n/a1
    Primary schools (LA maintained)3161Primary academies1323
    Special schoolsn/a4

    0 = the source returned zero. n/a = not held at this level. No data = no value returned; this does not mean zero.

    Sources & context

    Gaps are modelled estimates against benchmark rates; local assets as supplied

    Powered by Coplug · Page 11 of 15
    12 / 15

    Options for the PCN

    Options for the PCN

    Each option in full

    Option 1

    Hypertension review for patients under 80

    Across 10,446 hypertension patients, control under age 80 fell 2.8 pp over 2023 to 2025 (England +2.1 pp) to 66.4% (Stockport 70.8%; England 67.8%; 65.3% at Heaton Moor Medical Group). Moderate effort to run.

    Evidence base: the hypertension register is the cohort for case-finding, blood-pressure control and AF anticoagulation; its size and growth set the workload those interventions must cover, and a shortfall in control shows up later as emergency admission.

    Policy anchor: Core20PLUS5 (hypertension case-finding and optimal management); NHS CVD ambitions to 2029 on detection, treatment to target and statins for high-risk patients (CVDPREVENT).

    Option 2

    Structured annual asthma review recall

    Across 5,142 asthma patients (7.6% QOF prevalence vs England 6.6 percent), 12-month review coverage (denominator incl. PCAs) is 59.6% (Stockport (LAD) 63.4 percent; England 65.7 percent), after a 3-year change of -3.1 pp over 2023 to 2025 (England +2.8 pp), leaving 2,077 (about 2,100) patients without a recorded review. Low cost, quick to run.

    Evidence base: the annual asthma review is the process gap between the register and outcomes.

    Policy anchor: Core20PLUS5 chronic respiratory disease priority.

    Option 3

    Combined SMI physical health check outreach

    Across 846 SMI patients (1.2% prevalence; England 1.0%), 12-month BP recording is 79.3% (Stockport 85.0%; England 83.4%) and BMI recording is 79.7% (Stockport 84.0%; England 82.1%). For discussion: practices could offer combined single-visit physical health checks, audit partial component coding, and raise shared-care data reconciliation with mental health system partners. Moderate effort to run.

    Evidence base: the SMI register is the cohort for the annual physical health check; the alcohol record is the delivery measure for alcohol screening and brief intervention.

    Policy anchor: Mental Health Investment Standard; NHS alcohol care teams and the From Harm to Hope strategy.

    Sources & context

    Options are the profile's; evidence base from Coplug's indicator catalogue

    Powered by Coplug · Page 12 of 15
    13 / 15

    Provenance and audit trail

    Provenance and audit trail

    Figures are the profile's, drawn from Coplug indicator tables: census, deprivation and QOF measures, MHCLG, Rough sleeping snapshot in England: autumn 2025, OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713) and OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002). Every recommended action and option is the profile's own; the evidence-base statements that support them — what each register is the cohort for, and the national policy it serves — are quoted from Coplug's indicator catalogue. No recommendation in this report is authored outside the profile and that catalogue. ICB- and provider-level data (page 8) describes the system the PCN sits in and is not read as PCN performance.

    RecommendationIndicator(s)Policy anchorData level
    Older adult resource allocation (p2)Aged 65+Neighbourhood health framework · NHS vaccination strategyPCN
    Two-track Core20 resource allocation (p3)Core20 cohort (IMD quintile 1)Core20PLUS5 · 10YHP equity testPCN
    Physical health check recall (p4)SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Hypertension clinical review protocol (p5)Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs)Core20PLUS5 CVD · CVDPREVENT 2029PCN
    Pre-school booster catch-up (p6)4-in-1 pre-school booster (DTaP/IPV) coverage at age 510YHP sickness to prevention · 95% targetPCN
    Targeted breast screening recall (p7)Breast screening coverage: aged 53 to 70 years old—PCN
    Telephony and triage process review (p9)GPPS easy to contact the practice by phone10YHP, hospital to communityPractice
    Option 1 · Hypertension review for patients under 80 (p12)Hypertension register · Last BP reading of patients (<80 yrs with hypertension) in the last 12 months is <= 140/90 mmHg (denominator incl. PCAs) · Hypertension patients with a recent BP readingCore20PLUS5 CVD · CVDPREVENT 2029PCN & Practice
    Option 2 · Structured annual asthma review recall (p12)Asthma register · Asthma: QOF prevalence · Patients with Asthma: review in the last 12 months (denominator incl. PCAs)Core20PLUS5 respiratoryPCN
    Option 3 · Combined SMI physical health check outreach (p12)Severe mental illness register · Severe mental illness: QOF prevalence · SMI register with a BP check in the last 12 monthsMHIS · From Harm to HopePCN
    Sources & context

    Re-run this profile in 12 months to see whether the gaps have narrowed

    Powered by Coplug · Page 13 of 15
    14 / 15

    Data sources

    Data sources

    Every figure in this profile comes from a dataset below, at the level and period stated. Nothing published above PCN level is read as PCN performance.

    DatasetLevelPeriodUsed for
    Coplug indicator tables: census, deprivation and QOF measuresPCN & Practice2023 to 2025, projected to 2030; 2023 to 2024Pages 1, 2, 3, 4, 5, 6, 7, 8, 10, 12
    MHCLG, Rough sleeping snapshot in England: autumn 2025Local authorityAutumn 2025Pages 2, 4
    OHID, Fingertips diabetes by frailty status: HbA1c control (93712, 93713)PCN2024/25Pages 2, 4
    OHID, Fingertips falls: emergency admissions, 65+ and 65 to 79 (22401, 22402), accidental-fall deaths (94002)Local authority2024/25; 2022-24Pages 2, 4
    ONS, Census 2021 TS039: provision of unpaid care (age-standardised)Local authorityCensus 2021Pages 2, 4
    QOF registers, prevalence and care processes (Coplug indicator tables)Practice2023 to 2025, projected to 2030Pages 4, 5, 6, 7, 8, 10
    UKHSA, COVER supplementary GP data, childhood immunisation coverage, Q1 2025/26PCN & PracticeQ1 2025/26Pages 4, 6
    UKHSA, Seasonal influenza vaccine uptake in GP patients, 2025 to 2026Local authority2025/26 season to 28 Feb 2026Pages 4, 6
    NHS England, Cancer Waiting Times: July 2026 monthly time series with revisionsICB & ProviderJul 2026 (provisional)Pages 7, 8
    NHS England, Community Services Statistics (CSDS): June 2026 provisional experimental dataICB & Local authorityJun 2026 (provisional)Pages 7, 8
    NHS England, Monthly Diagnostics Waiting Times and Activity (DM01): provider by test, July 2026ProviderJul 2026Pages 7, 8
    National Disease Registration Service, Stage at diagnosis by cancer site in England, 2013 to 2022ICB2022Pages 7, 8
    NHS England / Ipsos, GP Patient Survey 2026: practice results (weighted)PracticeSurvey Jan-Apr 2026Page 9
    NHS England, Quality and Outcomes Framework 2025-26: achievement by practice and domainPractice2025/26Page 9
    NHS England, Quality and Outcomes Framework 2025-26: personalised care adjustments by practice and domainPractice2025/26Page 9
    Coplug indicator catalogue — definitions, cohorts, policy anchorsReferenceCurrentEvidence-base lines, page 13
    Sources & context

    Where a period is given as "as supplied", the source file did not state a vintage

    Powered by Coplug · Page 14 of 15
    15 / 15

    Methods, data-quality notes and limitations

    Methods, data-quality notes and limitations

    Methods

    Estimated gaps apply benchmark prevalence to the registered population and subtract the recorded register. They size the task; they are not confirmed missed patients.

    Percentage points are the difference between two rates; a relative change is that difference as a share of the starting rate. Register changes are relative, over three years.

    Forecasts to 2030 extend each indicator's current trajectory with no change in case-finding or service model: a baseline to act against, not a prediction.

    Core20 is the most deprived 20% nationally (IMD quintile 1). Practice shares are not additive to the PCN figure. Ethnic minority is 100% minus White. Local-authority averages are unweighted.

    Sources & context

    Estimates size the task; they are not confirmed missed patients

    Powered by Coplug · Page 15 of 15